Stepan reported a net loss of $41.4 million in Q1 2026 versus $19.7 million income a year earlier. The loss reflects a $65.4 million pre-tax restructuring charge, while adjusted net income fell 47% to $10.3 million and adjusted EBITDA declined 14% to $49.6 million.

Net sales rose 2% year-over-year to $604.5 million, driven by higher prices and favorable currency translation, while organic volume was flat. Surfactants adjusted EBITDA fell 15%, polymers grew 8%, and specialty products volume increased 30% despite margin pressures; cash from operations was $16.9 million and free cash flow was negative $14.0 million.

The board declared a quarterly cash dividend of $0.395 per share payable June 15 to holders of record June 1, marking the 58th consecutive annual increase. The company also entered a $30 million agreement to sell land near its Millsdale site, with closing expected in the second half of the year.